COVID-19 Pandemic Perspectives

"Regeneron has broadly neutralizing antibodies against MERS; this is currently already in clinical trials."

This fact is important to check since it establishes a claim about a drug that has shown efficacy that is already being studied through clinical trials. The Regeneron website verifies this fact that this new drug is being studied in clinical trials.

Original Source:
https://www.regeneron.com/covid19

Contents of this annotation: